- +234 (706) 546-0499
- admin@nidsconference2022.nids.org.ng
- NIDS, Abuja, Nigeria
Starting on -21 November 2022
Infectious disease preparedness and response: challenges and prospects in resource- constrained settings
Rudiments of publishing high impact articles: ideas for authors and editors
Antimicrobial resistance: Meeting the Global Action Plan targets in Nigeria
Private Sector involvement in infectious disease control.
Leveraging on PHEIC declaration to address the challenge of Monkeypox in Africa.
Improving access to COVID-19 Vaccines: lessons and strategies for Africa
Clinical Management of Lassa fever
Prof. Oyewale Tomori is a member of the Global Virome Project Leadership Board. He is the immediate past President of the Nigerian Academy of Science with experience in virology
Dr. Ifedayo Adetifa is the Director General of the Nigeria Centre for Disease Control and Prevention (NCDC). Dr. Adetifa is a paediatrician and epidemiologist.
Dr. Uche Unigwe is a consultant Infectious Disease physician and head of the Infectious Disease and Tropical Medicine units of the University of Nigeria Teaching Hospital (UNTH) Enugu
Iruka N Okeke is Professor of Pharmaceutical Microbiology and a Calestous Juma Science Leadership Fellow at the University of Ibadan, Nigeria. She is a Fellow of the Nigerian and African Academies of Science.
Dr Rosamund Lewis is the WHO Technical Lead for monkeypox and heads the Smallpox Secretariat of the WHO Health Emergencies Programme at WHO headquarters in Geneva.
Dr. Michael Onyebuchi Iroezindu is currently a Senior Lecturer in Infectious/Tropical Diseases and Internal Medicine at the Department of Medicine, College of Medicine, University of Nigeria; and an Honorary Consultant Physician at the University of Nigeria Teaching Hospital, Ituku/Ozalla, Enugu.
Dr. Gemma Alderton received her PhD in Biochemistry from the University of Sussex, where she researched DNA damage and cell cycle signalling pathways and their deregulation in human disease with Penny Jeggo.
Abdulrazaq G. Habib is a professor of infectious and tropical diseases and epidemiology. His researches focus on infectious diseases, tropical snakebite, and global health including COVID-19, with H-Index of 34 (June 2022).
Prof. Gregory Erhabor is an outstanding scholar, researcher and teacher. He is one of the foremost chest physicians in Africa. He singlehandedly established the Respiratory Unit of the Obafemi Awolowo University, Ile-Ife.
Join the Nigerian Infectious Diseases Society (NIDS) Annual conference 2022 on online via ZOOM
Starting: Nov 21, 2022 08:00 AM West Central Africa. After registering, you will receive a confirmation email containing information about joining the meeting..
ATTEND HYBRID YENAGOA 2022
The Registration to the NIDS AGSM Conference is mandatory to be enabled to attend the Sessions and to have the accepted Paper included in the published Conference Proceedings. To this end it is mandatory to complete the registration process and the Payment of the registration fee by November 21st, 2022
Attend in Person and Network with like-minded Medical Professional Infectious diseases. Widen the quality of your professional network as our Scientific Session bring together senior Medical Professionals in the industry.
Payment of this fee entitles the participant to the virtual scientific workshop.
Scientific Writing Workshop (virtual) ₦5,000
Payment should be made to the account details below:
Nigerian Infectious Disease Society ECOBANK 0537162999
Please send payment receipt to this WhatsApp number or call for enquiries: +234 803 056 0799.
Dr. Ifedayo Adetifa is the Director General of the Nigeria Centre for Disease Control and Prevention (NCDC). Dr. Adetifa is a paediatrician and epidemiologist whose work has covered areas of paediatric HIV/AIDS, tuberculosis and vaccine-preventable diseases epidemiology. He has focused on vaccine epidemiology research with a focus on evidence generation for vaccine policy in Africa through vaccine impact studies and seroepidemiology. He was a member of the Kenya SARS-CoV-2 Serology Consortium and is a member of the World Health Organization, African Region (WHO-AFRO) Regional Immunisation Technical Advisory Group, the WHO Respiratory Syncytial Virus Technical Advisory Group, and the Programme Advisory Group for the Malaria Vaccine Implementation Programme. Prior to leading the NCDC, he was an Associate Professor of Infectious Disease Epidemiology at the London School of Hygiene and Tropical Medicine (LSHTM) and Clinical Epidemiologist at the Kenya Medical Research Institute (KEMRI) – Wellcome Trust Research Programme (KWTRP) and prior, a Clinical Epidemiologist at the Medical Research Council Unit, The Gambia.
Iruka N Okeke is Professor of Pharmaceutical Microbiology and a Calestous Juma Science Leadership Fellow at the University of Ibadan, Nigeria. She is a Fellow of the Nigerian and African Academies of Science. Her research group uses microbiology, genetic and genomic methods to investigate the mechanisms bacteria use to colonize humans, cause disease and gain drug resistance. She also studies laboratory practice in Africa, contributes to collaborative genomic surveillance for antimicrobial resistance and communicates about microbiology to a broad range of stakeholders.
Iruka received B.Pharm., M.Sc. and Ph.D. degrees from Obafemi Awolowo University (formerly University of Ife), Nigeria and post-doctoral training at the University of Maryland, USA and Uppsala Universitet, Sweden. She has held Fulbright, International Federation for Science, Branco Weiss (Society-in-Science), Institute for Advanced Studies (Berlin) and MRC African Research Leader fellowships as well as academic positions in Nigeria, the UK and the USA. Iruka is author/ co-author of several scientific articles and chapters as well as the books Divining Without Seeds: The case for strengthening laboratory medicine in Africa (Cornell Univ Press) and Genetics: Genes, Genomes and Evolution (Oxford Univ Press). A teacher scholar, she has mentored over a hundred research students, the majority of whom continue to work in science and health.
Dr. Ifedayo Adetifa is the Director General of the Nigeria Centre for Disease Control and Prevention (NCDC). Dr. Adetifa is a paediatrician and epidemiologist whose work has covered areas of paediatric HIV/AIDS, tuberculosis and vaccine-preventable diseases epidemiology. He has focused on vaccine epidemiology research with a focus on evidence generation for vaccine policy in Africa through vaccine impact studies and seroepidemiology. He was a member of the Kenya SARS-CoV-2 Serology Consortium and is a member of the World Health Organization, African Region (WHO-AFRO) Regional Immunisation Technical Advisory Group, the WHO Respiratory Syncytial Virus Technical Advisory Group, and the Programme Advisory Group for the Malaria Vaccine Implementation Programme. Prior to leading the NCDC, he was an Associate Professor of Infectious Disease Epidemiology at the London School of Hygiene and Tropical Medicine (LSHTM) and Clinical Epidemiologist at the Kenya Medical Research Institute (KEMRI) – Wellcome Trust Research Programme (KWTRP) and prior, a Clinical Epidemiologist at the Medical Research Council Unit, The Gambia.
Dr. Ifedayo Adetifa is the Director General of the Nigeria Centre for Disease Control and Prevention (NCDC). Dr. Adetifa is a paediatrician and epidemiologist whose work has covered areas of paediatric HIV/AIDS, tuberculosis and vaccine-preventable diseases epidemiology. He has focused on vaccine epidemiology research with a focus on evidence generation for vaccine policy in Africa through vaccine impact studies and seroepidemiology. He was a member of the Kenya SARS-CoV-2 Serology Consortium and is a member of the World Health Organization, African Region (WHO-AFRO) Regional Immunisation Technical Advisory Group, the WHO Respiratory Syncytial Virus Technical Advisory Group, and the Programme Advisory Group for the Malaria Vaccine Implementation Programme. Prior to leading the NCDC, he was an Associate Professor of Infectious Disease Epidemiology at the London School of Hygiene and Tropical Medicine (LSHTM) and Clinical Epidemiologist at the Kenya Medical Research Institute (KEMRI) – Wellcome Trust Research Programme (KWTRP) and prior, a Clinical Epidemiologist at the Medical Research Council Unit, The Gambia.
Prof. Oyewale Tomori is a member of the Global Virome Project Leadership Board. He is the immediate past President of the Nigerian Academy of Science with experience in virology, disease prevention and control. He was at the University of Ibadan (Nigeria) from 1971 to 1994. He later served as the pioneer Vice Chancellor of the Redeemer’s University in Nigeria from 2004 to 2011.
From 1994 to 2004, he was a virologist for the World Health Organization (WHO)’s Africa Region, establishing the African Regional Polio Laboratory Network. In 1981, he was recognized by the U.S. Centers for Disease Control and Prevention (CDC) for contributions to Lassa fever research. In 2002, he received the Nigerian National Order of Merit, the country’s highest award for academic and intellectual attainment and national development. He has authored/co-authored over 150 scientific publications.
Dr Tomori has served or continues to serve on numerous advisory committees, including: (nationally) – Chair, Lassa Fever Steering Committee, National Laboratory Technical Working Group, Expert Working Group on Polio Eradication and Routine Immunization, and (internationally) – WHO SAGE, WHO Africa Regional Polio Certification Committee, WHO Group of Experts on Yellow Fever Disease, Chairman WHO Yellow Fever Emergency Committee on International Health Regulations, GAVI Board, Vice Chair of U.S. National Academy of Medicine Global Health Risk Framework Commission, and World Bank Interagency Working Group on Financing Preparedness and Response. He served as Laboratory Planning and Quality Monitoring Adviser to the WHO-AFRO Regional Director and as Chairman, Ministerial Expert Advisory Committee on Covid19 Health Sector Response, of the Nigerian government. He is an international member of the U.S. National Academy of Medicine, Board Chair of Biovaccines Nigeria Ltd. and a Senior Fellow at the Scowcroft Institute, Texas A&M University.
Uche Unigwe is a consultant Infectious Disease physician and head of the Infectious Disease and Tropical Medicine units of the University of Nigeria Teaching Hospital (UNTH) Enugu and Alex Ekwueme Federal University Teaching Hospital Abakaliki (AE-FUTHA). He has been the coordinator of the virology centre of the Alex Ekwueme Federal Teaching Hospital Abakaliki, a centre for the laboratory confirmation and clinical management of highly contagious diseases like Lassa. He is also coordinator and clinical head of the Isolation and treatment centre for COVID-19 in UNTH
He is a fellow of the West African College of Physicians with additional qualifications in Public Health (MPH) from the University of Nigeria and a master’s degree in Tropical Medicine (MTropMed) from the Nagasaki University Institute of Tropical Medicine (NUITM), Japan.
As consultant physician in the institutions mentioned above, he oversees clinical care of patients, lecturing, training and supervision of resident doctors and medical students, research activities, advisory/administrative roles to the institution as it relates to infectious diseases. Additionally, he is involved in clinical management, surveillance and enlightenment on emerging and re-emerging infectious diseases in these institutions and in the states of Enugu and Ebonyi where the institutions are domiciled. He trains medical and health workers on Infection prevention and control measures and principles especially of these high consequent infectious diseases. He is a member of the Lassa fever national committee.
He has been a consultant to the UK Partnership for Transforming Health Systems (PATHS) in Enugu state and the UNICEF A field office (comprising 10 states). As executive coordinator of the civil society organisation (CREASUP) he obtained grants/ funding to conduct several health -related community – based programs for both international organisations. In PATHS, he was involved in coordinating and facilitating the formation of facility health committees (FHCs) geared towards improving health services at the primary health centres as well as supportive supervision towards the implementation of the district health system and other health policies in Enugu state. He facilitated several workshops on malaria, reproductive health and childcare concepts in several states within the south-east and south- south zones of Nigeria on behalf of UNICEF.
He is a visiting researcher to Nagasaki University Institute of Tropical Medicine (NUITM) and has facilitated the collaboration between NUITM and institutions in Nigeria on Lassa fever and Neglected Tropical Diseases. He has several peer review publications and currently involved in some on-going researches as principal investigator or Co-Principal investigator.
He has presented in several national and international conferences. He is currently the secretary- general of the Nigerian infectious Disease Society (NIDS).
Dr Rosamund Lewis
Dr Rosamund Lewis is the WHO Technical Lead for monkeypox and heads the Smallpox Secretariat of the WHO Health Emergencies Programme at WHO headquarters in Geneva, leading on emergency preparedness for orthopoxviruses for the agency. A public health physician and medical epidemiologist, Rosamund has served WHO, the Government of Canada, and other agencies at global, national and municipal levels in emergency preparedness, health security, disease surveillance and response, offering country support for a range of immunization and disease control programmes. Other roles focused on field epidemiology in emergency settings (MSF/Epicentre) and new vaccines and health systems (GAVI / CIDA). Along with a Bachelor of Science and a Doctorate of Medicine degrees from McGill University, Rosamund holds a Master of Science in Epidemiology and Biostatistics, a Master of Management in Health Leadership, and fellowships in Family Medicine and in Public Health and Preventive Medicine. Rosamund has published extensively in her areas of work. Rosamund holds an appointment as Adjunct Professor in the School of Epidemiology and Public Health, University of Ottawa.
Sorry, Speakers is empty
MBBS (IB), FWACP, Dip. Chest Medicine (RCP, UK), FCCP (USA), FRCP (Edin), FRCP (Lond.)
Prof. Gregory Erhabor is an outstanding scholar, researcher and teacher. He is one of the foremost chest physicians in Africa. He singlehandedly established the Respiratory Unit of the Obafemi Awolowo University, Ile-Ife. In his early career, he made great breakthroughs in Asthma and did pioneering works in Exercise-Induced Asthma in Nigeria and Perception of Asthma and Breathlessness at the Lung Exercise Respiratory Department, Bristol Royal Infirmary, United Kingdom. He also pioneered research in Directly Observed Short-Course Therapy (DOTS) in Tuberculosis, in Ile-Ife, Nigeria.
He is a Fellow of the West African College of Physicians (FWACP), American College of Chest Physicians (FCCP), and the Royal Colleges of Physicians in Edinburgh (FRCP Edin) and London (FRCP Lond). He won the prestigious British Thoracic Society Award, being the only one awarded among the 70 people shortlisted globally. He has demonstrated academic leadership and has been involved in teaching and mentoring younger colleagues who have gone on to make outstanding breakthroughs in their careers. He has supervised over 36 residents who have successfully defended their dissertations and has co-supervised numerous others in other teaching hospitals. He has won numerous awards including ‘Making a Difference’ Award by American College of Chest Physicians in Philadelphia (2008), and Humanitarian Award in Asthma by American College of Chest Physicians in Atlanta, Georgia, USA, 2012.
He has taken several positions in the West African College of Physicians, prominent among which was Chief Examiner, Faculty of Internal Medicine. He is the Editor-in-Chief of the West African Journal of Medicine, a journal that serves Physicians and Surgeons in the West African Subregion, and has taken it to enviable heights, to the extent that they now publish monthly. He was former President of the Nigerian Thoracic Society and former Chairman, STOP-TB, Nigeria. He was the first international regent and governor of American College of Chest Physicians in Nigeria. He is presently an Executive Committee Member of the Council of Global Governors of the American College of Chest Physicians (ACCP). In the recent past, he served as Vice-Chair of the Chronic Lung Disease division of International Union Against Tuberculosis and Lung Diseases (IUATLD) based in Paris for three years, after being programme secretary for many years. Currently, he is a member of the 8-Member Governing Board of the Nigerian National Merit Award.
He was the Principal Investigator and Chair of the global multi-centre study – Burden of Obstructive Lung Disease Study (BOLD Study II), Nigeria Centre. He has written over one hundred and twenty (120) articles in peer reviewed national and international journals and has authored several books and chapters in respiratory medicine, including – Pulmonary Function Tests: Spirometry and Peak Flow in Clinical Practice & Asthma: Basic Principles and Management Strategy, and has published several booklets on asthma, tuberculosis and other chest diseases. He founded the Asthma and Chest Care Foundation that reaches out to people round the world.
Gemma Alderton received her PhD in Biochemistry from the University of Sussex, where she researched DNA damage and cell cycle signalling pathways and their deregulation in human disease with Penny Jeggo. Having established an interest in cell cycle signaling she worked as a postdoc in John Diffley’s lab at the Cancer Research UK Clare Hall laboratories, investigating the control of the G1/S checkpoint signaling in mammalian cells. In October 2006 she moved to Nature Reviews Cancer to continue to explore her broad interest in pathological cell signaling. In 2017, she became the biology Perspectives editor at Science and is now Deputy Editor of the Insights section at the journal, she commissions and publishes Perspectives and Reviews across biology, but especially in biomedicine.
Sorry, Speakers is empty
Sorry, Speakers is empty
Sorry, Speakers is empty
Golden Tulip hotel Yenagoa,
Tuesday, 21-24 November 2022